Asbjørn Hróbjartsson

Research interests

Publications

• CONSORT 2025 statement: updated guideline for reporting randomised trials

  BMJ · 2025 · https://doi.org/10.1136/bmj-2024-081123

• A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)

  Environment International · 2024 · https://doi.org/10.1016/j.envint.2024.108602

• A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas

  Revista Panamericana de Salud Pública · 2022 · https://doi.org/10.26633/rpsp.2022.112

• Efficacy and safety of COVID-19 vaccines

  Cochrane Database of Systematic Reviews · 2022 · https://doi.org/10.1002/14651858.cd015477

• Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas

  Revista Española de Cardiología · 2021 · 10.1016/j.recesp.2021.06.016

• Interleukin-6 blocking agents for treating COVID-19: a living systematic review

  Cochrane Database of Systematic Reviews · 2021 · https://doi.org/10.1002/14651858.cd013881

• PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

  BMJ · 2021 · https://doi.org/10.1136/bmj.n160

• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

  International Journal of Surgery · 2021 · https://doi.org/10.1016/j.ijsu.2021.105906

• The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

  Systematic Reviews · 2021 · https://doi.org/10.1186/s13643-021-01626-4

• Pravila PRISMA 2020.

  Medicina Fluminensis · 2021 · https://doi.org/10.21860/medflum2021_264903

• European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

  Journal of Pediatric Gastroenterology and Nutrition · 2019 · https://doi.org/10.1097/mpg.0000000000002497

• RoB 2: a revised tool for assessing risk of bias in randomised trials

  BMJ · 2019 · https://doi.org/10.1136/bmj.l4898

• ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

  BMJ · 2016 · https://doi.org/10.1136/bmj.i4919

• Differential Effectiveness of Placebo Treatments

  JAMA Internal Medicine · 2013 · https://doi.org/10.1001/jamainternmed.2013.10391

• SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

  Annals of Internal Medicine · 2013 · 10.7326/0003-4819-158-3-201302050-00583

• Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed

  Journal of Clinical Epidemiology · 2010 · 10.1016/j.jclinepi.2010.03.002

• Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials

  JAMA · 2004 · 10.1001/jama.291.20.2457

• Is the Placebo Powerless?

  New England Journal of Medicine · 2001 · 10.1056/nejm200105243442106

Current projects

No projects listed.